These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21854095)

  • 1. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
    Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
    Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
    [No Abstract]   [Full Text] [Related]  

  • 2. Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.
    Gheza F; Cervi E; Pulcini G; Villanacci V; Giulini SM; Schiavo-Lena M; Ferrari AB; Bassotti G
    Pancreas; 2011 Jul; 40(5):791-3. PubMed ID: 21673543
    [No Abstract]   [Full Text] [Related]  

  • 3. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
    Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
    J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
    Senatore FJ; Ynson ML; Dasanu CA
    J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
    Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
    Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
    Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
    Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
    Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
    Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
    Goldstein NS; Bassi D
    Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.
    Kohler I; Jacob D; Budzies J; Lehmann A; Weichert W; Schulz S; Neuhaus P; Röcken C
    Am J Clin Pathol; 2011 Feb; 135(2):202-11. PubMed ID: 21228360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
    Aburjania N; Truskinovsky AM; Overman MJ; Lou E
    J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
    [No Abstract]   [Full Text] [Related]  

  • 15. Periampullary carcinoma: some important news in histopathology.
    Uomo G
    JOP; 2014 Mar; 15(2):213-5. PubMed ID: 24618452
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
    Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
    Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
    Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
    Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
    Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA.
    Zhu L; Kim K; Domenico DR; Appert HE; Howard JM
    J Surg Oncol; 1996 Feb; 61(2):100-5. PubMed ID: 8606540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater.
    Kim ST; Lee J; Lee KT; Lee JK; Lee KH; Choi SH; Heo JS; Choi DW; Park SH; Park JO; Lim HY; Park YS; Kang WK
    Med Oncol; 2010 Dec; 27(4):1149-54. PubMed ID: 19898973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.